Ifp Advisors, Inc Kempharm, Inc Transaction History

Ifp Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$4.12 - $5.62 $32,960 - $44,960	-8,000 Reduced 86.49%	1,250 $18,000
Q2 2022 Sep 06, 2022	BUY	$4.02 - $5.21 $37,184 - $48,192	9,250 New	9,250 $134,000
Q2 2022 Aug 12, 2022	SELL	$4.02 - $5.21 $37,184 - $48,192	-9,250 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$5.0 - $9.26 $40,000 - $74,080	8,000 Added 640.0%	9,250 $46,000
Q2 2021 Jul 13, 2021	SELL	$8.52 - $15.47 $4,728 - $8,585	-555 Reduced 30.75%	1,250 $16,000
Q1 2021 Apr 30, 2021	BUY	$5.6 - $13.47 $3,108 - $7,475	555 Added 44.4%	1,805 $17,000
Q4 2020 Jan 25, 2021	BUY	$8.0 - $18.72 $10,000 - $23,400	1,250 New	1,250 $14,000

116

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.